Increased electroretinogram a‐wave amplitude after intravitreal bevacizumab injection for neovascular age‐related macular degeneration

. Purpose: To assess the effect of bevacizumab (Avastin®), a vascular endothelial growth factor inhibitor, on retinal function by full‐field electroretinography (ERG) in patients with neovascular age‐related macular degeneration (AMD). Design: A prospective, nonrandomized, controlled interventiona...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Acta ophthalmologica (Oxford, England) Ročník 89; číslo 3; s. e269 - e273
Hlavní autoři:	Skaat, Alon, Solomon, Arie, Moroz, Iris, Hai, Orit Vidne, Rechtman, Ehud, Vishnevskia Dai, Vicktoria, Rotenstreich, Ygal
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Oxford, UK Blackwell Publishing Ltd 01.05.2011
Témata:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Bevacizumab bevacizumab (Avastin®) Choroidal Neovascularization - drug therapy Choroidal Neovascularization - physiopathology Electroretinography Female full‐field electroretinography Humans Intravitreal Injections Macular Degeneration - drug therapy Macular Degeneration - physiopathology Male Middle Aged neovascular age‐related macular degeneration Photic Stimulation Prospective Studies Retina - physiology Vascular Endothelial Growth Factor A - antagonists & inhibitors
ISSN:	1755-375X, 1755-3768, 1755-3768
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!